Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
103.00    -1.50 (-1.44%)
Bid:
102.70
Ask:
103.50
Spread: 0.80 (0.779%)
Market Cap: £382.30m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

AGM Statement

22 Feb 2023 07:00

RNS Number : 6304Q
RWS Holdings PLC
22 February 2023
 

For immediate release 22 February 2023

 

RWS Holdings plc

AGM Statement

RWS Holdings plc ("RWS", "the Group" or "the Company"), a unique world-leading provider of technology-enabled language, content and intellectual property services, is today holding its Annual General Meeting at which Andrew Brode, Chairman, will make the following remarks:

"The Company delivered another robust set of results in FY22 against a backdrop of continued economic uncertainty and the ongoing conflict in Eastern Europe. The Group produced cash-generative, profitable growth in line with market expectations, continued its unbroken record of dividend growth and made good progress on the actions and investments that we set out at our Capital Markets Day (CMD) in March 2022.

Current trading and outlook

"The Group continues to focus on delivering its medium-term strategy, despite the continuing macroeconomic challenges. The investments that we outlined at last year's CMD are progressing well and we are pleased to have completed the first of our transformation programmes early in 2023, with a successful move to a single Microsoft collaboration platform across the whole Group.

"Our full year outlook remains in line with market expectations¹, underpinned by a number of new client wins and continued strong retention amongst existing clients, albeit with certain projects now expected to start in the second half. While trading in IP Services continues to be impacted by the advent of the Unitary Patent (UP), it remains on track for the year, despite a short delay to the UP's implementation which we now expect will come into operation in June. These factors, together with the impact of our growth initiatives, underpin our expectation of an acceleration of organic growth in the second half.

"We remain pleased with the progress of our investments in technology where the depth of experience we have in developing and training AI engines is of increasing importance to our industry and to our clients. The forthcoming launch of our enhanced AI data services offering will further position the Group well to capitalise on the growth of AI solutions as highlighted at our CMD last year.

"Our unique capabilities, diverse client base, geographical spread and end-market exposure, combined with our strong cash generation and balance sheet, underpin our resilience, our confidence in the opportunities provided by the multiple growth drivers across our markets, and our ability to make attractive acquisitions." 

1 The latest Group-compiled view of analysts' expectations for FY 2023 gives a range of £771.8m-£782.6m for revenue, with a consensus of £779.2m; a range of £127.9m-£136.5m for adjusted profit before tax, with a consensus of £133.3m, and a range of 24.5p to 26.6p for adjusted EPS, with a consensus of 25.9p.

 

RWS published its first standalone Environmental, Social and Governance Report on 27 January 2023. This comprehensive review sets out our progress in FY22 and is available on the Group's website (www.rws.com/about/corporate-sustainability/).

 

About RWS

RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our unique combination of technology and cultural expertise helps our clients to grow by ensuring they are understood anywhere, in any language. 

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

We work with over 80% of the world's top 100 brands, more than three-quarters of Fortune's 20 'Most Admired Companies' and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L). 

For further information, please visit: www.rws.com.

 

RWS Holdings plc 01753 480200

Andrew Brode, Chairman

Ian El-Mokadem, Chief Executive Officer

Candy Davies, Chief Financial Officer

MHP (Financial PR advisor) rws@mhpgroup.com

Katie Hunt / Simon Hockridge 020 3128 8100

Numis (Nomad & Joint Broker) 020 7260 1000

Stuart Skinner / Kevin Cruickshank / Will Baunton

Berenberg (Joint Broker) 020 3207 7800

Ben Wright / Toby Flaux / Alix Mecklenburg-Solodkoff 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMEAEAFAFKDEAA
Date   Source Headline
1st Oct 20257:00 amRNSTotal Voting Rights
1st Sep 20253:09 pmRNSTotal Voting Rights
28th Aug 20257:00 amRNSHolding(s) in Company
18th Aug 20257:00 amRNSHolding(s) in Company
8th Aug 202511:11 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 20257:00 amRNSDirector/PDMR Shareholding
28th Jul 20259:25 amRNSHolding(s) in Company
23rd Jul 20254:29 pmRNSHolding(s) in Company
18th Jul 20251:19 pmRNSHolding(s) in Company - amendment
16th Jul 20254:01 pmRNSHolding(s) in Company
2nd Jul 20259:00 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSChange of Nominated Adviser
26th Jun 202511:00 amRNS-RAcquisition of IP of Papercup
23rd Jun 202510:46 amRNSHolding(s) in Company
18th Jun 202512:30 pmRNSHolding(s) in Company
18th Jun 202510:12 amRNSHolding(s) in Company
17th Jun 202511:29 amRNSFurther re Half Year Report
17th Jun 20257:00 amRNSHalf-year Report
11th Jun 20257:00 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSHolding(s) in Company
6th Jun 20257:00 amRNSHolding(s) in Company
2nd Jun 20257:00 amRNSTotal Voting Rights
12th May 20259:15 amRNS-RAppointment of Chief Product & Technology Officer
8th May 202511:51 amRNSDirector/PDMR Shareholding
6th May 202510:10 amRNSHolding(s) in Company
2nd May 20259:15 amRNSHolding(s) in Company
1st May 20252:15 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSHolding(s) in Company
29th Apr 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSHolding(s) in Company
25th Apr 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSTrading Statement
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSChange of Registered Office
3rd Mar 20258:55 amRNSTotal Voting Rights
14th Feb 20253:51 pmRNSHolding(s) in Company
13th Feb 202512:33 pmRNSDirector/PDMR Shareholding
11th Feb 202512:14 pmRNSResult of AGM
11th Feb 20257:00 amRNSAGM Statement
10th Feb 20254:57 pmRNSHolding(s) in Company
3rd Feb 20255:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20254:58 pmRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSTotal Voting Rights
28th Jan 20252:06 pmRNSDirector/PDMR Shareholding
28th Jan 20252:04 pmRNSDirector/PDMR Shareholding
28th Jan 20252:01 pmRNSDirector/PDMR Shareholding
23rd Jan 20253:58 pmRNSOption Exercise, Admission and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.